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012.07.0Abstract We report our local experience in using the non contact mapping system in guiding cath-
eter ablation of unstable/non sustained Ventricular tachycardia (VT) and its short and long term
implications.
Patients and methods: This report includes 18 cardiomyopathic patients, 13 males, age 40.5 ± 15
yrs, who presented to our centre with VT that share in common being unstable or non sustained.
The patients were subjected to radiofrequency catheter ablation guided by the non contact mapping
system.
Results: Acute successful outcome was obtained in 6 out of 8 (75%) patients with scar related VTs
(post myocardial infarction and arrhythmogenic right ventricular dysplasia) and 9 of 10 (90%)
patients with idiopathic dilated cardiomyopathy. Long term follow up for 6–24 (16 ± 8) months
showed recurrence in one case of the scar related group and in two cases of the idiopathic group,
so the overall long term success rates were 62.5% vs 70% (P. NS). Regular Echocardiographic
showed an improvement of 10–15% in the Ejection Fraction in successful cases of the idiopathic
group (Average Post-ablation EF in the idiopathic group of 49 ± 5% vs pre-ablation EF of
41 ± 4% while 42 ± 6 pre Vs 42 ± 7% post ablation in the scar related group) (P< 0.01).
Conclusion: Non contact mapping guided RF ablation of unstable VT in patients with cardiomyop-
athy showed good immediate results and long term outcome both in scar related and in idiopathic
cardiomyopathy patients. Successful RF ablation of non sustained ventricular dysrhythmias among
patients with idiopathic Cardiomyopathy may improve LV dysfunction.
ª 2012 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved..com (S. Atta).
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011. Introduction
Radiofrequency (RF) catheter ablation is an effective therapy
for stable monomorphic ventricular tachycardia (VT) in
patients with and without structural heart disease. New
mapping tools have been developed (Carto, Localisa, Realtimeg by Elsevier B.V. All rights reserved.
204 S. Atta et al.Position Management) which create maps that correlate anat-
omy with cardiac electrical activation to facilitate RF ablation
of complex arrhythmias.1,2 However, these systems require
stable tachycardia to be able to create the activation map. In
case of unstable ventricular tachycardia not allowing activa-
tion mapping, systems which provide global mapping data as
non-contact mapping system were reported to give good
restults.3,4
With global mapping methods, substrates for short-lived
and multiple arrhythmias can be deﬁned, the data stored,
and an ablation catheter navigated to the chosen site(s)
enabling ablation of the target either during sinus rhythm or
at the onset of a VT that would otherwise be of short duration.
This has been conﬁrmed by the experience using non-contact
mapping when all target and many other VTs were successfully
ablated.4,5
In this study, we report our local experience in using the non
contact mapping system in guiding RF catheter ablation of
unstable ventricular tachycardias in patients with different
types of cardiomyopathy and its short and long term outcomes.
2. Patients and methods
All patients with symptomatic unstable VT in patients with
cardiomyopathy referred to the electrophysiology Laboratory
of Saud Al-babtain Cardiac Centre (SBCC), Ad-Dammam,
KSA, between December 2008 and May 2011, for the trial of
RF ablation were included in the study.
2.1. Inclusion criteria
1. Signiﬁcant unstable VT either due to haemodynamic
unstability with disturbing symptoms like syncope, pre-
syncope that necessitate immediate termination of the
VT, or frequent non sustained symptomatic VT with
a signiﬁcant daily arrhythmic burden P20% linked
to LV systolic dysfunction.
2. Refractoriness to drug therapy or inappropriateness of
medical treatment.
2.2. Exclusion criteria
I. Patients with poor prognosis due to non cardiac causes
as end stage malignancy, signiﬁcant renal or hepatic
diseases were excluded from the study.
II. Patients with reversible ischaemic heart disease until
fully investigated and any required revascularization
is done.
III. Local causes that hinder implementing the procedure
as LV thrombus or severe peripheral vascular disease
and inability to go trans-septally if LV is the target.
 The study was approved by the local ethics committee
of the Centre and patients gave informed written con-
sents before including in the study.
 The patients were subjected to full clinical assessment, 12
lead ECG, X-ray chest, ventricular tachycardia was
deﬁned with standard electrocardiographic criteria of at
least ﬁve consecutive premature ventricular contractions(PVC) at a rate >120 beats/min. Echocardiographic
assessment to assess LV function, LV ejection fraction
(EF) and exclude left ventricular thrombus.We evaluated
the chamber size of LV and right ventricle (RV), and
degree of mitral regurgitation at parasternal long-axis
or apical four-chamber view, respectively. All values of
echocardiogram were recorded during sinus rhythm, but
not at the PVC beat, nor at the post-PVC beat. All
patients also Anti-arrhythmic drugs as Amiodarone,
Sotalol, Beta blocker alone or in combinations had been
unsuccessful for variable periods before the patients were
subjected to RF ablation (Patients’ characteristics are
shown in Table 1).
2.3. Electrophysiological study and mapping technique
Electrophysiological testing and RF catheter ablation were
performed in the fasting state. Anti-arrhythmic drugs other
than amiodarone were discontinued one week before the study.
The stimulation protocol consisted of programmed ventric-
ular stimulation from the right ventricular apex and outﬂow
tract (RVOT) at four different cycle lengths with up to three
premature extra-stimuli. Surface ECG leads and endocardial
electrograms were displayed and recorded simultaneously at
a speed of 100 or 200 mm/s. Data were stored on an optical
CD-Rom for further evaluation. The induced VT was initially
localized to either ventricle by comparing timing of RV and
LV recorded electrograms to decide the ventricle to map.
Before deployment of the multi-electrode array balloon
(MEA), patients were given 10,000 IU heparin IV injection
with later boluses to maintain activated clotting time at 300
to 400 s. The MEA catheter was deployed via the retrograde
trans-aortic route if the LV is the target chamber except in
one patient who had severe peripheral vascular disease and
we had to go through the trans-septal approach. If the RV is
the target chamber, the venous femoral-caval approach was
used for introducing the MEA.
2.4. The mapping procedure using the Ensite system
The non-contact mapping system and the principles of its use
were described in details previously.3,5 Ventricular tachycardia
induced with programmed electrical stimulation was then re-
corded using the noncontact computerized mapping system
for at least half a minute if it can be haemodynamically toler-
ated for this period, otherwise, recording for few seconds was
considered before overstimulation of the recorded tachycardia.
The virtual unipolar electrograms and isopotential maps were
used for ofﬂine analysis of the recorded VTs to trace the exit,
the presystolic and diastolic activation during VT, zones of
slow conduction moving back from VT exit sites as described
before6 (Fig. 1). Also voltage maps were used to identify scar
areas by very low amplitude electrograms <0.5 mV, while
voltage between 0.5 and 1.5 mV was considered mixed border-
line tissues and >1.5 mV was coded as healthy tissues accord-
ing to a previous suggested criteria.7–10
2.5. Ablation policy
Radiofrequency ablation using an 8 mm tip IBI ablation cath-
eter (Biotronic-Germany) with energy up to 50 W titrated to a
Table 1 Criteria of individual patients serially(F: female, M: male, NS VT: non sustained ventricular tachycardia, LV: left ventricular,
RVOT: right ventricular outﬂow tract, ARVCM: arrhythmogenic right ventricular cardiomyopathy, IHD: ischemic heart disease, MI:
myocardial infarction.
# Age
(ys)
Sex Aetiology of
cardiomyopathy
VT type Site of origin Pre-EF Post-EF Result of ablation
1 43 M Post MI (IHD) Incessant post
myocardial infarction
VT
LV BASAL
INFERIOR SEPTAL
30% 35% Successful ABLATION
2 30 F Idiopathic LV
dysfunction
VT arised from
subpulmonary free
wall RVOT
RVOT VT 45% 55% Successful Ablation
3 28 F ARVCM Unstable VT RV inferoseptal
position
50% 50% FAILED
4 16 M Idiopathic LV PVCs/NS VT Monomorphic PVCs,
LV MID TO APICAL
INFEROSEPTAL
45% 45% Successful ABLATION
5 33 M Idiopathic LV VT Successful ablation,
MID SEPTAL
37% 50% Successful ablation
6 29 F Idiopathic RVOT PVCs High POSTERO-
SEPTAL RVOT
30% 45% Successful Ablation
7 22 M Idiopathic RV PVCs/NS VT, VT Not identiﬁed 40% 40% Failed Ablation OF
RVOT VEs
8 50 M Idiopathic RVOT PVCs/NS VT RVOT, (Inferoposterior
septal Wall)
40% 55% Successful Ablation OF
RVOT VEs
9 35 M ARVCM RV PVCs/NS VT, VT RV basal septal 50% 50% Successful ABLATION
PVCs
10 45 M Idiopathic LVOT non sustained
VT
LVOT NSVT 40% 45% Successful ABLATION
11 58 M Post MI (IHD) Incessant VT LV MID SEPTAL 25% 25% SUCCESSFUL
ABLATION
12 73 F Post MI (IHD) Post MI unstable VT LV mid anterior septum 40% 43% Successful ablation, late
Recurrence
13 29 M Idiopathic RVOT NSVT RVOT 45% 57% SUCCESSFUL
Ablation
14 62 M Post MI (IHD) Haemodynamically
unstable VT
LV basal MID TO Ant.
Septum
35% 35% Successful ablation
15 37 F ARVCM, Early
Recurrence
PVCs, NS VT, VT
from the RV body
RV basal Ant. Septum 55% 55% Successful RF ablation
16 45 M Idiopathic RVOT non sustained
VT
Anteroseptal RVOT
just below the PV
45% 45% Successful RF ablation
17 56 M Idiopathic RVOT non sustained
VT
Low Anterior RVOT 45% 55% Successful RF ablation
18 40 M Post Inferior MI
(IHD)
Unstable VT LV BASAL
INFERIOR SEPTAL
40% 40% Successful VT ablation
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AC was administered by the use of a continuous sinusoidal
unmodulated waveform of 500 kHz (Stockert GMBH ablation
system). Energy was delivered between the tip electrode of the
ablation catheter and a 10 · 16-cm external back plate elec-
trode. In all patients, RF pulses were applied during sinus
rhythm. Energy application was continued at each site rather
than performing drag lesions and the lines were completed
according to Ensite map.
In scar related VTs, when re-entry was the responsible
mechanism, the linear lesions were attempted to produce lines
of conduction block across the areas of diastolic activities and/
or slow conduction and/or connecting two scar areas or from a
scar to an anatomic boundary across an isthmus. Then the
conduction block across the Lines was tested by tracing the im-
pulse propagation during pacing using the Ensite propagation
map analysis and then testing the non inducibility of the VT
thereafter. In post inferior infarction patients, special attentionwas given to the sub-mitral isthmus such that the energy deliv-
ery was continued to extend the line up to the mitral valve ring.
In cases when the nature of the tachycardia was found to be
focal in origin, RF lesions were directed to the identiﬁed exit in
an areal manner to isolate the identiﬁed exit. After the set of
lesions is completed, the VT inducibility or spontaneous occur-
rence was retested.
We deﬁned immediate success as non inducibility of the
previously inducible targeted clinical VTs at the end of the pro-
cedure; acute success was deﬁned as no clinical recurrence dur-
ing the hospital stay i.e. during the 1st 5 days post ablation,
short term success within 3 months and Long term success if
beyond 3 months.
2.6. Follow-up
After the ablation session, all patients had continuous ECG
monitoring for at least 5 days or until ICD implantation if
Figure 1 3D constructed left ventricular geometry using the Ensite system with ofﬂine analysis of the ventricular tachycardia in a post
inferior wall MI patient showing a part of the diastolic pathway of the ventricular tachycardia across the sub-mitral annulus.
206 S. Atta et al.implantation was planned. Clinical follow up and Echocardi-
ography were performed for 1 to 2 days and at 1 and 3 months
then 6 months after the ablation procedure and changes in
Ventricular functions were observed.
2.7. Statistics
Continuous variables are presented as mean and SD and com-
pared using the Student’s t test for unpaired data. Categorical
data were compared by x2 analysis. Regarding success rates
and EF changes in relation to the ablation method and the sta-
tistical signiﬁcance of the results were analysed by Chi-square
test, and the exact Fisher’s test. Values of P< 0.05 were con-
sidered signiﬁcant.
3. Results
This report includes 18 patients, 12 males,of age 40.5 ± 15 yrs,
presenting to our centre in Saud Albabtain Cardiac Centre,
KSA with ventricular dysrhythmias that share in common
being unmappable by the activation mapping techniques due
to unstable non sustained nature of the tachycardia or unsta-
bility of the patient during the attack necessitating immediate
termination. They included 5 patients with ischaemic Heart
disease with a previous myocardial infarction (MI) (3 post
inferior and 2 post anterior MI), 3 patients with Arrhythmo-
genic Right Ventricular Cardiomyopathy (ARVC) and 10 pa-
tients with idiopathic dilated cardiomyopathy in whom IHD
was excluded either by myocardial perfusion imaging (MPI)
or coronary angiography (CAG) and with no signiﬁcant scar
as assessed by MPI. The average pre-ablation Left ventricular
ejection fraction (EF) was 41 ± 7%, ranging from 25% to
55%. ALL the ischaemic heart disease patients had already
been revascularized – by percutaneous Coronary Intervention
(PCI) in 4 patients and by Redo Coronary Artery Bypass
Graft (CABG) Surgery in the ﬁfth patient – before referralto the EP laboratory. 3 patients had previously undergone deﬁ-
brillator implantation as a part of the treatment of life-threat-
ening ventricular arrhythmias. Other 5 patients received it later
after the procedure. The indications for ablation of VT were
Recurrent episodes of documented haemodynamically unsta-
ble monomorphic VT in 5 patients post MI with frequent
ICD shocks in three patients of them with already implanted
ICDs. Rest of the patients had symptomatic palpitation and
syncope in 3 patients with ARVD, and frequent non sustained
VT/PVCs in 10 patients with impaired LV function thought to
be secondary to the signiﬁcant burden of repetitive non sus-
tained VT (>20% of the 24 h Heartbeats).
3.1. Results of the mapping and ablation procedures
The overall duration of the procedure was 146.5 ± 35 min,
average ﬂuoroscopic exposure time of 27.5 ± 12 min, average
RF pulses 20 ± 8 (7–40 RF pulses). By programmed stimula-
tion, 23 VT morphologies with a CL of (230–330,
260 ± 50 ms) were induced and targeted for ablation. 12
VTs were induced in scar related cardiomyopathy patients: 7
morphologies in 5 patients with post MI VT and 5 morpholo-
gies in 3 ARVC patients. Ofﬂine investigator analysis of the
isopotential maps was variable according to the complexity
of the substrate and number of induced VTs reaching up to
30 min in some cases.
The VT mapping by the Ensite system showed re-entry as
the responsible mechanism of VT in all scar related VT cases
(8 cases). Exit sites could be identiﬁed and a diastolic pathway
could be traced for a variable interval (50–160 ms) in the 12 VT
morphologies induced in patients with scar related VTs
(Fig. 1). Guided by the propagation map and the voltage scar
maps, Lines of RF lesions in the range of 23–40 RF pulses
(30 ± 8) were required according to the ablation policy men-
tioned above to reach the end point of non inducibility of
the VT (Fig. 2).
Figure 2 3D constructed left ventricular geometry by the Ensite system showing line of RF ablation across the sub-mitral isthmus done
according to the VT pathway analysis in the case with VT after inferior wall myocardial infarction shown in Fig. 1.
Table 2 Comparison of characteristics and outcome of patients included in the report. (VT: ventricular tachycardia, NSVT: non
sustained ventricular tachycardia, PVCs: premature ventricular contractions, EF: ejection fraction, RF: radiofrequency, NS: non
signiﬁcant).
Patient Scar related VT group Idiopathic cardiomyopathy NSVT/PVCs P. value
Number of patients 8 10
Age 51 ± 16 yrs 33 ± 10 yrs
Male 6 7 NS
Pre-ablation EF 42 ± 7% 41 ± 4% NS
Tried Anti-arrhythmic drugs 4 ± 1 3 ± 1
No of inducible VTs 12 11 ??NS
VT site of origin (LV/RV) 5/3 3/7
Duration of procedures 176.6 ± 22 min 85 ± 25 min <0.01
Fluoroscopy duration 42.5 ± 12 min 25 ± 10 min <0.05
Number of RF pulses 30 ± 8 11 ± 5 <0.05
Acute Success rate 75% 90% NS
Long term success rate 62.5% 70% NS
Post ablation EF 42 ± 6% 49 ± 5% P< 0.01
Cases with post ablation improvement of EF Non/8 6/10 P< 0.001
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had LV origin and 7 patients found to have RV origin (5 from
RVOT and 2 from RV body) and all showed a focal origin of
VT and were targeted by exit isolation by RF lesions in the
range 5–16 (11 ± 5) RF pulses till abolishment and noninduc-
ibility of the targeted ventricular arrhythmia. The number of
RF pulses required was signiﬁcantly less in patients with idio-
pathic forms compared to scar related VTs. The duration of
the procedure and ﬂuoroscopy exposure was signiﬁcantly less
also in the idiopathic group (Table 2).
Overall, acute successful outcome was obtained in 15 pa-
tients (83%) while ablation failed in three patients: One post
MI case with recurrent unstable VT after a redo CABG who
had an electrical storm short after his redo CABG and was
uncontrollable by medical treatment. During the ablation pro-
cedure, the patient had again an electrical storm with 2 VTmorphologies and their pathways were targeted by lines of
RF ablations according to our ablation policy in the scar re-
lated patients. The trial of RF ablation was initially followed
by 12 h of stability and non recurrence then the patient had
a recurrent VT that became partially controllable by medical
treatment. One week later, this patient died in a refractory
VT/VF. The 2nd failed case had ARVC and the VT remained
inducible despite performing a line of RF lesions across the
path of the VT connecting two scars across the VT isthmus.
The VT remained inducible with the changes in its pathway
and morphology. The third case had frequent non sustained
VT in an idiopathic cardiomyopathy patient, thought origi-
nally from the ECG and by the initial provisional crude bipo-
lar localization to arise from the RVOT. However, the origin
of the VT could not be localized on the endocardial side of
the RVOT using the non contact mapping analysis and all
208 S. Atta et al.trials of ablation on the earliest points could not eliminate the
VT.
3.2. Post ablation follow up
During long term follow up of 6–24 (16 ± 8) months, late
recurrence was observed in three cases. Two cases belonged
to the idiopathic cardiomyopathy patients, one case with
recurrent non sustained VT from the RV body and another
case with LV tachycardia with overall long term success rate
in that group of 70%. The third long term recurrence occurred
in one of the post MI patients i.e. belonged to the scar related
group, with overall long term success rate in this group of
62.5%, however with no signiﬁcant difference from the idio-
pathic group (Table 2).
Regular Echocardiography assessment during the follow up
period showed an improvement of 10–15% in the EF in 6
successful cases all belonging to the idiopathic group with an
average post ablation EF of 49 ± 5% compared to the pre-
ablation EF of 41 ± 4%%. The scar related group did not
show a similar change (Post ablation EF of 42 ± 7% vs.
pre-ablation 42 ± 6%)(P value <0.01). (Table 2)
3.2.1. Complications
No deaths or strokes were directly related to the procedure,
limited local femoral haematoma occurred in two cases.
4. Discussion
The difﬁculty of the ablation procedure increases when
unmappable VTs are present. Many laboratories restrict abla-
tion attempts to patients with mappable VTs. Sacher et al. doc-
ument that unstable VT is present in more than two thirds of
patients with structural heart disease who are undergoing abla-
tive therapy.11 VT that is unmappable with a single roving
catheter may be mapped with a system that simultaneously re-
cords electrograms throughout the ventricle during one or a
few beats of the unstable VT, following which the VT can be
terminated to allow ablation during stable sinus rhythm. This
may be achieved by using a system that records electrical
potentials from an electrode grid array within the cavity of
the ventricle as the Ensite non contact mapping system (Endo-
cardial Solutions, St Paul, Minnesota, USA). Sites of early
endocardial activity, which are likely adjacent to re-entry cir-
cuit exits, are usually identiﬁable; in some cases, isthmuses
and diastolic pathways have been identiﬁed.3,5
In our study, we used the non contact mapping system to re-
cord and analyse unstable ventricular dysrhythmias in cardio-
myopathic patients of different pathologies. In patients whom
the VT is scar related as patients after myocardial infarction
or patients with ARVC, the VT mechanisms were found to
be re-entrant in nature. In patients with idiopathic cardiomyop-
athy, non sustained ventricular dysrhythmias showed focal ori-
gin except in one case when VT exit could not be precisely
determined and the nature of the VT was obscure. The voltage
scar mapping could help in addition to the VT circuit analysis
in guiding the RF applications done during sinus rhythm in pa-
tients with scar related VT and this resulted in acute success in
about 75% of the cases. Failure in one post MI patient was
associated with early mortality while over the long term follow
up, one further recurrence occurred in this group.Targeting unmappable VTs was tried in many reports using
different techniques. Ellison and colleagues targeted the likely
re-entry exit region in ﬁve patients with frequent unmappable
VT.9 They did mapping during sinus rhythm and performed
ablation over a region of identiﬁable scar that contains abnor-
mal conduction and a presumptive VT exit guided by pace
mapping. All three patients with prior myocardial infarction
were free of recurrent VT during follow ups of 14–22 months.
The procedure was not successful in two cases with non-ischae-
mic cardiomyopathy.
The voltage scar mapping and ablation of untolerated VTs
by RF applications during sinus rhythm using electroanatomic
mapping (Carto System) was described by Marchlinski et al.
and they used voltage deﬁnitions of scar, borderline and nor-
mal myocardium which was later adopted in other studies
and we used the same criteria in our study. They applied a
more extensive series of RF ablation lines through regions of
scar in 16 patients with recurrent unmappable VT (prior myo-
cardial infarction in nine patients) guided by bipolar catheter
mapping during baseline rhythm. The amount of endocardium
with an abnormal electrogram amplitude was estimated using
ﬂuoroscopy in 3 patients and the magnetic mapping system
(CARTO) in 13 patients. For the magnetic mapping, normal
endocardium was deﬁned by an amplitude >1.5 mV; this mea-
surement was based on sinus rhythm maps in 6 patients who
did not have structural heart disease. Radiofrequency point le-
sions were extended linearly from the ‘‘dense scar’’ which had a
voltage amplitude <0.5 mV, to anatomic boundaries or nor-
mal endocardium to limit radiofrequency applications.10 Dur-
ing a median follow up of eight months 75% remained free of
VT recurrences. One patient suffered a stroke, emphasizing the
potential risk of placing extensive lesions in the left ventricle.
In a post-mortem study, these voltage thresholds correlated
very well with histology, since massive (>80%) ﬁbrosis has
been found in areas with voltage <0.5 mV, while intermediate
(21%–79%) and minimal (<20%) ﬁbrosis have been observed
in areas with voltage 0.5–1.5 mV and > 1.5 mV, respectively.12
A similar methodology to ours, applied in similar patient
groups was described previously by Della Bella et al. They
used the non contact mapping system to guide RF ablation
of unmappable VT in patients with cardiomyopathy of differ-
ent aetiologies.6 The placement of linear lesions, by radiofre-
quency current, across the diastolic pathway resulted in
successful ablation of 78% of targeted ventricular tachycardias
in patients with scar related VTs. The rationale of the ablation
design was to create a line of block extending across the dia-
stolic pathway thus preventing sustained re-entry. These
results are not far from our results in this category of patients.
However, the results in ARVC and idiopathic group in our
report are better than what was reported by this group where
Catheter ablation was completely effective in only 1/3 of
patients (33%) with arrhythmogenic right ventricular dysplasia
and 1/3 (33%) of patients with idiopathic dilated cardiomyop-
athy in their report.
Arrhythmogenic right ventricular cardiomyopathy is asso-
ciated with ﬁbrous and fatty scar tissue in the right and often
the left ventricles. When right ventricular involvement is exten-
sive, the success of ablation is variable.13,14 Individual VTs can
be ablated, but others may develop later, possibly related to
progression of the disease process. Ablation is reserved as a
palliative treatment for frequent episodes. Although the right
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mapping does not seem to be substantially increased. In a
recent report by Nair et al., long term outcome of using the
Ensite non contact mapping in patients with ARVC was as-
sessed. In 13 out of 15 patients, all the clinical and inducible
VTs were ablated. In two patients, non-clinical inducible
VTs could not be ablated. At 25 ± 16 months (2–52 months),
all patients remained asymptomatic. Two patients had the
recurrence of non-clinical VT on follow-up.14 Despite includ-
ing much less number of ARVC patients in our study, how-
ever, the results reported by Nair et al. is generally similar to
our results in our limited number of patients with ARVC.
It is uncertain, whether frequent non sustained VT/PVCs
cause LV dilation and dysfunction even in patients with no evi-
dence of structural heart disease and, if so, whether suppression
of this non sustained dysrhythmias improves these changes.
However, It has been previously reported that frequent PVC
caused left ventricular (LV) dysfunction that can be reversed
by suppression of PVC with anti-arrhythmic agents15,16 or
radiofrequency catheter ablation (RFA)4,5 in patients with di-
lated cardiomyopathy. It has been reported that RFA produces
clinical beneﬁts to the patients with ventricular tachycardia,17–19
and some case reports have shown that the dilated cardiomyop-
athy patients with PVC-depressed cardiac function and success-
ful RFA of these arrhythmias improved LV function.20,21 In a
study by Takemoto et al., A subgroup of patients with frequent
(>20%) PVC demonstrated signiﬁcantly enlarged LVDd re-
duced LVEF, increased mitral regurgitation, and deteriorated
NYHA functional class as compared to the subgroup with rare
(>20%) PVC. Furthermore, the ablation of these arrhythmias
with acute success rate of 93% was associated with the normal-
ization of these abnormalities without adverse effects and they
suggested thatRadiofrequency catheter ablationmay be consid-
ered as the ﬁrst choice of therapy for those patients.22 Our pa-
tients with dilated cardiomyopathy with no structural heart
disease andwith frequent PVCs/NSVT>20%per day, had sim-
ilar success rates of ablation and a signiﬁcant improvement of
functional state and LV function after a successful ablation.
So, our ﬁndings also support the assumption that frequent
PVCs/NSVT may be a possible cause of LV dysfunction and/
or heart failure and successful suppression of these dysrhyth-
mias may improve LV dysfunction among the patients with idi-
opathic cardiomyopathy.
5. Conclusion
In our growing experience, non contact mapping guided RF
ablation of unstable VT in patients with ventricular dysfunc-
tion showed good immediate results and long term outcome.
This may be as effective in scar related VTs as in idiopathic
cardiomyopathy types. Successful RF ablation of frequent
repetitive non sustained ventricular dysrhythmias among
patients with idiopathic Cardiomyopathy may improve LV
dysfunction.Acknowledgement
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